Arcturus Awarded $63.2M to Advance Self-amplifying mRNA Vaccine for Pandemic Influenza Response
$63.2 Million base award to fund development from preclinical stage through Phase 1 over three-year period. A lower-dose, freeze-dried, pandemic influenza ...